Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Emerging Team Grant: HIV/AIDS Vaccine Discovery & Social Research - LOI

University of Toronto

$10,000.00

Enhancing Care and Prevention in HIV Vaccine Trials: An International, Interdisciplinary Collaboration

EF 2009-10

Résumé
The discovery of a safe and effective preventive vaccine is the best hope for controlling the global AIDS epidemic. To that end, clinical trials involving thousands of human volunteers will need to be conducted for the foreseeable future. Efficacy trials (to determine if a vaccine is effective in preventing HIV infection or not), in particular, involve high-risk volunteers often from vulnerable communities, including the developing world. The objective of this international, interdisciplinary and participatory research program is to identify and mitigate social, behavioral and health risks among volunteers and potential volunteers in HIV vaccine trials¿in Canada, India, Kenya, South Africa and Thailand. The purpose of the research program is to build an evidence base to ensure the highest standards of care and prevention in safe, ethically and justly conducted HIV vaccine trials.
Programme
Emerging Team Grant: HIV/AIDS Vaccine Discovery & Social Research - LOI
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
188582
Name
Newman Peter A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Emerging Team Grant : HIV/AIDS Vaccine Discovery and Social Research
Projecttitle
Enhancing Care and Prevention in HIV Vaccine Trials: An International, Interdisciplinary Collaboration
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Emerging Team Grant: HIV/AIDS Vaccine Discovery & Social Research - LOI
Keyworddelim
Clinical Trials; Developing World; Hiv Vaccine; Risk Compensation; Standards Of Care; Survey Research
Abstract
The discovery of a safe and effective preventive vaccine is the best hope for controlling the global AIDS epidemic. To that end, clinical trials involving thousands of human volunteers will need to be conducted for the foreseeable future. Efficacy trials (to determine if a vaccine is effective in preventing HIV infection or not), in particular, involve high-risk volunteers often from vulnerable communities, including the developing world. The objective of this international, interdisciplinary and participatory research program is to identify and mitigate social, behavioral and health risks among volunteers and potential volunteers in HIV vaccine trials¿in Canada, India, Kenya, South Africa and Thailand. The purpose of the research program is to build an evidence base to ensure the highest standards of care and prevention in safe, ethically and justly conducted HIV vaccine trials.
Competitiondate
200907
Approvedterm2
1 yr 0 mth
Pinamesdelim
Newman, Peter A; Lester, Richard T; Mills, Edward J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $10,000~ $0~